Apyx Medical (APYX)
(Delayed Data from NSDQ)
$1.19 USD
+0.02 (1.71%)
Updated Sep 24, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Price, Consensus and EPS Surprise
APYX 1.19 +0.02(1.71%)
Will APYX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for APYX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for APYX
Reasons to Retain Revvity Stock in Your Portfolio for Now
Butterfly Network's Stock Surges on iQ3 Device Launch in Europe
APYX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
Other News for APYX
Apyx Medical management to meet virtually with Craig-Hallum
Apyx Medical management to meet virtually with Craig-Hallum
Renuvion Named #1 Trusted Body Contouring Technology by Doctors*
Apyx Medical Corporation (APYX) Q2 2024 Earnings Call Transcript
Apyx Medical price target lowered by $2 at Craig-Hallum, here's why